NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 27 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $29,000 | -54.0% | 101,800 | 0.0% | 0.00% | – |
| Q2 2015 | $63,000 | -55.0% | 101,800 | -50.0% | 0.00% | – |
| Q1 2015 | $140,000 | +118.8% | 203,600 | +100.0% | 0.00% | – |
| Q4 2014 | $64,000 | -24.7% | 101,800 | 0.0% | 0.00% | – |
| Q3 2014 | $85,000 | +6.2% | 101,800 | 0.0% | 0.00% | – |
| Q2 2014 | $80,000 | -32.8% | 101,800 | 0.0% | 0.00% | – |
| Q1 2014 | $119,000 | – | 101,800 | +66873.7% | 0.00% | – |
| Q4 2013 | $0 | – | 152 | +2940.0% | 0.00% | – |
| Q3 2013 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARRISON BRADFORD & ASSOCIATES INC | 147,000 | $123,000 | 0.12% |
| Orbitronix, LP | 200,000 | $168,000 | 0.10% |
| WEDBUSH SECURITIES INC | 303,276 | $255,000 | 0.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 34,679 | $29,000 | 0.01% |
| BOSTON FAMILY OFFICE LLC | 17,500 | $15,000 | 0.00% |
| GLENMEDE TRUST CO NA | 300,000 | $252,000 | 0.00% |
| RONALD BLUE & CO LLC | 12,000 | $10,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 62,023 | $52,000 | 0.00% |
| MORGAN STANLEY | 2,500 | $2,000 | 0.00% |
| NEW ENGLAND SECURITIES CORP /MA/ | 600 | $1,000 | 0.00% |